Alberti, K.G., Zimmet, P. and Shaw, J., 2006. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Medicine 23, 469-480. Crossref, Google Scholar
	Alvarez-Blasco, F., Botella-Carretero, J.I., San Millan, J.L. and Escobar-Morreale, H.F., 2006. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 166, 2081-2086. Crossref, Google Scholar
	Anonymous, 2004a. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25. Crossref, Google Scholar
	Anonymous, 2004b. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41-47. Crossref, Google Scholar
	Anonymous, 2012. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Human Reproduction 27, 14-24. Crossref, Google Scholar
	Apridonidze, T., Essah, P.A., Iuorno, M.J. and Nestler, J.E., 2005. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90, 1929-1935. Crossref, Google Scholar
	Attaoua, R., Ait El Mkadem, S., Radian, S., Fica, S., Hanzu, F., Albu, A., Gheorghiu, M., Coculescu, M. and Grigorescu, F., 2008. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochemical and Biophysical Research Communications 373, 230-234. Crossref, Google Scholar
	Balkau, B. and Charles, M.A., 1999. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Medicine 16, 442-443. Crossref, Google Scholar
	Bentley-Lewis, R., Seely, E. and Dunaif, A., 2011. Ovarian hypertension: polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America 40, 433-449, ix-x. Crossref, Google Scholar
	Caliskan, E., Kilic, T., Bodur, H. and Zeteroglu, S., 2007. The frequency of metabolic syndrome in women with polycystic ovaries at reproductive age and comparison of different diagnostic criteria for metabolic syndrome. Journal of the Turkish German Gynecological Association 8, 402-407. Google Scholar
	Carmina, E., Napoli, N., Longo, R.A., Rini, G.B. and Lobo, R.A., 2006. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. European Journal of Endocrinology 154, 141-145. Crossref, Google Scholar
	Cheung, L.P., Ma, R.C., Lam, P.M., Lok, I.H., Haines, C.J., So, W.Y., Tong, P.C., Cockram, C.S., Chow, C.C. and Goggins, W.B., 2008. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Human Reproduction 23, 1431-1438. Crossref, Google Scholar
	Coviello, A.D., Legro, R.S. and Dunaif, A., 2006. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 91, 492-497. Crossref, Google Scholar
	Cussons, A.J., Watts, G.F., Burke, V., Shaw, J.E., Zimmet, P.Z. and Stuckey, B.G., 2008. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Human Reproduction 23, 2352-2358. Crossref, Google Scholar
	DeUgarte, C.M., Bartolucci, A.A. and Azziz, R., 2005. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility 83, 1454-1460. Crossref, Google Scholar
	Dokras, A., Bochner, M., Hollinrake, E., Markham, S., Vanvoorhis, B. and Jagasia, D.H., 2005. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstetrics and Gynecology 106, 131-137. Crossref, Google Scholar
	Dunaif, A., 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800. Google Scholar
	Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L., Cavaghan, M.K. and Imperial, J., 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141-146. Crossref, Google Scholar
	Essah, P.A., Wickham, E.P. and Nestler, J.E., 2007. The metabolic syndrome in polycystic ovary syndrome. Clinical Obstetrics and Gynecology 50, 205-225. Crossref, Google Scholar
	Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, 2001. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285, 2486-2497. Crossref, Google Scholar
	Faloia, E., Canibus, P., Gatti, C., Frezza, F., Santangelo, M., Garrapa, G.G. and Boscaro, M., 2004. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. Journal of Endocrinological Investigation 27, 424-429. Crossref, Google Scholar
	Gulcelik, N.E., Aral, Y., Serter, R. and Koc, G., 2008. Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome. Journal of the National Medical Association 100, 64-68. Crossref, Google Scholar
	Hart, R., Doherty, D.A., Mori, T., Huang, R.C., Norman, R.J., Franks, S., Sloboda, D., Beilin, L. and Hickey, M., 2011. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertility and Sterility 95, 2347-2353, 2353 e2341. Crossref, Google Scholar
	Holte, J., Bergh, T., Berne, C., Berglund, L. and Lithell, H., 1994. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism 78, 1052-1058. Google Scholar
	Jean Hailes Foundation for Women’s Health on behalf of the PCOS Australian Alliance, 2011. Evidence-based guideline for the assessment and management of polycystic ovary syndrome. National Health and Medical Research Councel, Melbourne, Australia. Available at: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/ext_2_ext_0002.pdf. Google Scholar
	Legro, R.S., Blanche, P., Krauss, R.M. and Lobo, R.A., 1999. Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. Fertility and Sterility 72, 990-995. Crossref, Google Scholar
	Legro, R.S., Kunselman, A.R. and Dunaif, A., 2001. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. American Journal of Medicine 111, 607-613. Crossref, Google Scholar
	Leibel, N.I., Baumann, E.E., Kocherginsky, M. and Rosenfield, R.L., 2006. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 91, 1275-1283. Crossref, Google Scholar
	Li, X.J., Yu, Y.X., Liu, C.Q., Zhang, W., Zhang, H.J., Yan, B., Wang, L.Y., Yang, S.Y. and Zhang, S.H., 2011. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clinical Endocrinology 74, 332-339. Crossref, Google Scholar
	Lord, J., Thomas, R., Fox, B., Acharya, U. and Wilkin, T., 2006. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 113, 1203-1209. Crossref, Google Scholar
	Marshall, J.C. and Dunaif, A., 2012. Should all women with PCOS be treated for insulin resistance? Fertility and Sterility 97, 18-22. Crossref, Google Scholar
	Moran, L.J., Hutchison, S.K., Norman, R.J. and Teede, H.J., 2011. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, CD007506. Google Scholar
	Moran, L.J., Misso, M.L., Wild, R.A. and Norman, R.J., 2010. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 16, 347-363. Crossref, Google Scholar
	Moran, L.J., Pasquali, R., Teede, H.J., Hoeger, K.M. and Norman, R.J., 2009. Treatment of obesity in polycystic ovary syndrome: a position statement of the androgen excess and polycystic ovary syndrome society. Fertility and Sterility 92, 1966-1982. Crossref, Google Scholar
	Norman, R.J., Masters, L., Milner, C.R., Wang, J.X. and Davies, M.J., 2001. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Human Reproduction 16, 1995-1998. Crossref, Google Scholar
	Palomba, S., Falbo, A., Zullo, F. and Orio Jr., F., 2009. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrine Reviews 30, 1-50. Crossref, Google Scholar
	Reaven, G., 2002. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106, 286-288. Crossref, Google Scholar
	Shaw, L.J., Bairey Merz, C.N., Azziz, R., Stanczyk, F.Z., Sopko, G., Braunstein, G.D., Kelsey, S.F., Kip, K.E., Cooper-Dehoff, R.M., Johnson, B.D., Vaccarino, V., Reis, S.E., Bittner, V., Hodgson, T.K., Rogers, W. and Pepine, C.J., 2008. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health – National Heart, Lung, and Blood Institute sponsored Women’s Ischemia Syndrome Evaluation. Journal of Clinical Endocrinology and Metabolism 93, 1276-1284. Crossref, Google Scholar
	Shroff, R., Kerchner, A., Maifeld, M., Van Beek, E.J., Jagasia, D. and Dokras, A., 2007a. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. Journal of Clinical Endocrinology and Metabolism 92, 4609-4614. Crossref, Google Scholar
	Shroff, R., Syrop, C.H., Davis, W., Van Voorhis, B.J. and Dokras, A., 2007b. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertility and Sterility 88, 1389-1395. Crossref, Google Scholar
	The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41-47. Crossref, Google Scholar
	Vrbikova, J., Vondra, K., Cibula, D., Dvorakova, K., Stanicka, S., Sramkova, D., Sindelka, G., Hill, M., Bendlova, B. and Skrha, J., 2005. Metabolic syndrome in young Czech women with polycystic ovary syndrome. Human Reproduction 20, 3328-3332. Crossref, Google Scholar
	Welt, C.K., Gudmundsson, J.A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G. and Crowley, W.F., 2006. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism 91, 4842-4848. Crossref, Google Scholar
	Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H.F., Futterweit, W., Lobo, R., Norman, R.J., Talbott, E. and Dumesic, D.A., 2010. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. Journal of Clinical Endocrinology and Metabolism 95, 2038-2049. Crossref, Google Scholar
	World Health Organization (WHO), 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, WHO, Geneva, Switzerland. Available at: http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf. Google Scholar
	Yildirim, B., Sabir, N. and Kaleli, B., 2003. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertility and Sterility 79, 1358-1364. Crossref, Google Scholar